Search clinical trials for: PASI,

Total 46 results

Hospices Civils de Lyon

Terminated

Clinical Evaluation of Implant-secured Removable Partial Denture (PASI-PAC)

Tooth Loss

France
Novartis Pharmaceuticals

Completed

Evaluation of the Effectiveness of Secukinumab in Patients With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

United States
University of Pavia
IRCCS Policlinico S. Matteo

Completed

Diabetes and Psoriasis

Diabetes | Psoriasis

Italy
ASIS Corporation

Unknown

ASIS for Enbrel in Plaque Psoriasis (ASISinPP)

Plaque Psoriasis.

United States
Centre Hospitalier Universitaire de Nice
Pfizer; Fotofinder

Completed

PASIMAT: Automatic Measure of PASI (PASIMAT)

Psoriasis
Amgen

Completed

Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis

Psoriasis-Type Psoriasis | Plaque-Type Psoriasis

United States
The Hospital District of Satakunta

Unknown

Comparison of Strut Coverage With OPTIMAX Versus SYNERGY Stents (OPTIMAX-OCT)

Acute Coronary Syndrome

Finland, Belgium
EXcorLab GmbH
Membrana GmbH; Nikkiso Co. Ltd; Nikkiso Medical GmbH

Terminated

Granulocytapheresis in Psoriasis (GRIP)

Psoriasis

Germany
University Hospital, Gentofte, Copenhagen

Unknown

GLP-1 Receptors in Normal Skin and Skin From Patients With Psoriasis

Reduction of Psoriasis Following Liraglutide Therapy in Terms of PASI and DLQI

Denmark
Pfizer

Completed

Multiple Dose Escalation Study In Medically Stable Subjects With Psoriasis

Psoriasis | Immunomodulation

United States
Annesofie Faurschou
University of Copenhagen

Completed

The Effect of Glucagon Like Peptide (GLP)-1 in Psoriasis

Psoriasis

Denmark
Innovaderm Research Inc.

Recruiting

Study to Assess the Reliability of PASI Scoring Using Digital-Based Images

Plaque Psoriasis

Canada
Novartis Pharmaceuticals

Completed

Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients

Psoriasis, Plaque-type Psoriasis

United States
Dana-Farber Cancer Institute
AstraZeneca

Recruiting

Osimertinib In EGFR Mutant Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States
Medical University of Graz

Completed

Etanercept Plus UVB-311nm Phototherapy in Psoriasis

Psoriasis

Austria
Dana-Farber Cancer Institute

Recruiting

Investigating Hereditary Risk In Thoracic Cancers (INHERIT) (INHERIT)

Lung Cancer | Genetic Disease | Genetic Predisposition | Hereditary Diseases

United States
Amgen

Completed

AMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis Subjects

Psoriasis
Amgen

Completed

Phase II Study of Apremilast (CC-10004) in Adults With in Psoriatic Arthritis

Psoriatic Arthritis

Belgium, Canada, United Kingdom, Germany, Netherlands
GlaxoSmithKline
PPD; ERT: Clinical Trial Technology Solutions; Q2 Solutions

Withdrawn

GSK2894512 Vehicle-Controlled Study for Adult Plaque Psoriasis

Psoriasis
Boston University
Corino Therapeutics, Inc.

Completed

Short-term Effects of TOLCAPONE on Transthyretin Stability in Subjects With Leptomeningeal TTR Amyloidosis (ATTR)

Transthyretin Amyloidosis | Amyloidosis, Leptomeningeal, Transthyretin-Related

United States
Abbott
Assign Data Management and Biostatistics GmbH

Completed

Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biologic Disease Modifying Anti-rheumatic Drugs (QUALITY)

Psoriasis Chronic

Austria
Technische Universität Dresden

Unknown

Investigation of Antipsoriatic Effects of UVB-induced Synthesis of 1alpha, 25-Dihydroxyvitamin D3 (1alpha, 25(OH)2D3, Calcitriol)in Keratinocytes of Psoriatic Skin, Using Cytochrom-P(CYP)Inhibitor Ketokonazol (VITAKET)

Psoriasis Vulgaris

Germany
Hospices Civils de Lyon

Completed

Evaluation of the Tolerance of Ceftaroline and Ceftobiprole in the Management of BJI / PJI

Antibiotic Reaction | Bone and Joint Infection

France
Novartis Pharmaceuticals

Withdrawn

Assessment of Efficacy and Safety of Secukinumab in Adult Patients in Turkish Population

Psoriasis
University of Turku
Academy of Finland

Unknown

Efficacy of Systemic Glucocorticoid in the Treatment of Wheezing in Children (VINKU)

Wheezing

Finland
Novartis Pharmaceuticals

Terminated

A Study of Secukinumab Treatment in Patients With Plaque Psoriasis and Coexisting Non-alcoholic Fatty Liver Disease (NAFLD) (pINPOINt)

Plaque Psoriasis | Non-alcoholic Fatty Liver Disease

Germany, Spain
Association Francaise pour la Recherche Thermale
University Hospital, Grenoble; Floralis

Completed

Evaluation of Spa Therapy in the Treatment of Plaque Psoriasis

Plaque Psoriasis

France
AstraZeneca

Terminated

Study to Determine if AZD0284 is Effective and Safe in Treating Plaque Psoriasis (DERMIS)

Plaque Psoriasis Vulgaris

Denmark
University Hospital Inselspital, Berne

Recruiting

Prevalence of Attributable Etiology and Modifiable Stroke Risk Factors in Patients With Covert Brain Infarctions (CBI-Registry)

Silent Cerebral Infarct | Silent Stroke | Silent Brain Infarction | Covert Brain Infarct | Covert Brain Infarction | Lacune

Switzerland, France
Amgen
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®)

Psoriatic Arthritis
The Hospital District of Satakunta

Unknown

Comparison of Titanium-Nitride-Oxide Coated Bio-Active-Stent (Optimax™) to the Drug (Everolimus) -Eluting Stent (Synergy™) in Acute Coronary Syndrome (TIDES-ACS)

Myocardial Infarction | Atherosclerosis | Percutaneous Coronary Intervention

Finland
Pfizer

Completed

Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Psoriasis

United States, Canada
Dana-Farber Cancer Institute

Recruiting

Biology of Young Lung Cancer Study: The YOUNG LUNG Study

Small Cell Lung Carcinoma | Non Small Cell Lung Cancer

United States
Pontificia Universidad Catolica de Chile

Completed

Effect of Vitamin D Supplementation on Metabolic Parameters of Patients With Psoriasis

Psoriasis | Metabolic Syndrome | Vitamin D Deficiency

Chile
Centre Hospitalier Régional d'Orléans

Recruiting

Effect of Vibratory Tendon Stimulation on Muscle Fatigue in the Acute Post-stroke Phase (VIBRAMAIN1)

Stroke | Fatigue | Stroke, Acute

France
Ahava Dead Sea Laboratories

Unknown

The Efficacy Of A Dead Sea Mineral Enriched Body Cream vs Its Carrier as an Adjuvant Treatment For Psoriatic Patients

Psoriasis Vulgaris

Israel
Chulalongkorn University

Unknown

Efficacy of Vitamin D3 for the Treatment of Psoriatic Patients With Vitamin D Deficiency and Insufficiency

Vitamin D Deficiency | Psoriasis Vulgaris

Thailand
Novartis Pharmaceuticals

Completed

Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab

Moderate to Severe Plaque-type Psoriasis

Germany, United States, Belgium, Colombia, Spain, Estonia, Hungary, Japan, Lithuania, Taiwan, Australia, Korea, Republic of, Canada, Singapore, Italy, Israel, Sweden, Guatemala, United Kingdom, Argentina, France, Poland, Latvia, Iceland, Finla... and more
Biomendex Oy

Recruiting

Clinical Study to Evaluate Adaptos®Ortho Wedge Bone Graft Substitute in High Tibial Osteotomy

Knee Deformity

Finland
Novartis Pharmaceuticals

Completed

Study of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque Psoriasis (STEPin)

Plaque Psoriasis

Spain, United Kingdom, Estonia, Germany, Bulgaria, Finland, Hungary, Poland, Argentina, Canada, Denmark, Switzerland, Sweden
GlaxoSmithKline

Completed

A Dose Ranging Study to Evaluate the Safety and Efficacy of GSK2586184 in Patients With Chronic Plaque Psoriasis

Psoriasis

Germany, United Kingdom
Novartis Pharmaceuticals

Completed

A 24-week, Multicenter, proSpective stUdy to Evaluate the PASI 90 Clinical Response Rate and the Safety PRofile of sEcukinuMab 300 mg in Cw6-negativE and Cw6-positive Patients With Moderate to Severe Chronic Plaque-type Psoriasis (SUPREME) (SUPREME)

Plaque Type Psorisis

Italy
Pasi A. Janne, MD, PhD
Massachusetts General Hospital; Dana-Farber Cancer Institute; Beth Israel Deaconess... and other collaborators

Completed

Erlotinib in Women With Previously Untreated Adenocarcinoma of the Lung

Adenocarcinoma | Non-small Cell Lung Cancer

United States
AbbVie (prior sponsor, Abbott)
Raffeiner GmbH

Completed

Effectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbidities (EPIC)

Moderate to Severe Plaque Psoriasis
Aarhus University Hospital

Active, not recruiting

Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLAR Study (MEMPSOLAR)

Skin Diseases | Psoriasis | Skin Diseases, Papulosquamous | Psoriasis Vulgaris | Skin and Connective Tissue Diseases

Denmark
CellAegis US, Inc.

Unknown

Remote Ischemic Conditioning Using the autoRIC (SHIELD)

Ischemia-Reperfusion Injury

Canada, United States

Search clinical trials for: PASI,

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations